Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Melanoma × Restraint, Physical × Clear all

Status

Completed 2 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms 1 Melanoma 1 Genetic Diseases, Inborn 1 Fatigue 1 Cardiotoxicity 1 Cardiomyopathies 1

Interventions

Nivolumab 22 pembrolizumab 16 Ipilimumab 13 Temozolomide 11 toripalimab 9 Biopsy 8 Dacarbazine 7 Blood Specimen Collection 7 Cyclophosphamide 6 trametinib 5 fludarabine 5 dabrafenib 5 camrelizumab 5 atezolizumab 5 durvalumab 4 binimetinib 4 aldesleukin 4 Interleukin-2 4 Injections 4 Gene Expression Profiling 4 Chemotherapy, Adjuvant 4 palbociclib 3 encorafenib 3 apatinib 3 Sorafenib 3 Introns 3 Cisplatin 3 Carboplatin 3 Canvaxin 3 Bevacizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00445783 2013-08-12

Study of Families With Melanoma

National Cancer Institute (NCI)

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡